Deloitte cuts weight-loss GLP-1 coverage and raises health insurance costs for US staff
Key points
- Deloitte will cut coverage of GLP-1 drugs used for weight loss for US staff, according to Business Insider.
- Deloitte is also raising health insurance costs for US staff.
- Traders Union linked the move to rising health benefit costs.
Deloitte is cutting coverage of GLP-1 drugs for weight loss and raising health insurance costs for its US staff, Business Insider reported. Traders Union linked the move to rising health benefit costs.
Original report: Traders Union ↗AI-assisted brief; may contain inaccuracies. Rely on the original reports and official documents. For information only; not legal, immigration or insurance advice.